Shyam Ajay Gokani

Dr. Shyam Ajay Gokani

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2023 in American Journal of Rhinology & Allergy
Verified
Journal Article
Open access
SGShyam Ajay Gokani
Shyam Ajay Gokani
AEAndreas Espehana
Andreas Espehana
APAna C. Pratas
Ana C. Pratas
LLLouis Luke
Louis Luke
ESEkta Sharma
Ekta Sharma
CPCarl Philpott
Carl Philpott
Background: Chronic rhinosinusitis (CRS) is a heterogeneous condition characterized by differing inflammatory endotypes. The identification of suitable biomarkers could enable personalized approaches to treatment selection. Objective: This study aimed to identify and summarize clinical studies of biomarkers in adults with CRS in order to inform future research into CRS endotypes. Methods: We conducted systematic searches of MEDLINE and Web of Science from inception to January 30, 2022 and included all clinical studies of adult CRS patients and healthy controls measuring biomarkers using enzyme-linked immunosorbent assays or Luminex immunoassays. Outcomes included the name and tissue type of identified biomarkers and expression patterns within CRS phenotypes. Study quality was assessed using the National Institutes of Health quality assessment tool for observational cohort and cross-sectional studies. A narrative synthesis was performed. Results: We identified 78 relevant studies involving up to 9394 patients, predominantly with CRS with nasal polyposis. Studies identified 80 biomarkers from nasal tissue, 25 from nasal secretions, 14 from nasal lavage fluid, 24 from serum, and one from urine. The majority of biomarkers found to distinguish CRS phenotypes were identified in nasal tissue, especially in nasal polyps. Serum biomarkers were more commonly found to differentiate CRS from controls. The most frequently measured biomarker was IL-5, followed by IL-13 and IL-4. Serum IgE, IL-17, pentraxin-3 and nasal phospho-janus kinase 2, IL-5, IL-6, IL-17A, granulocyte-colony stimulating factor, and interferon gamma were identified as correlated with disease severity. Conclusion: We have identified numerous potential biomarkers to differentiate a range of CRS phenotypes. Future studies should focus on the prognostic role of nasal tissue biomarkers or expand on the more limited studies of nasal secretions and nasal lavage fluid. We registered this study in PROSPERO (CRD42022302787).

1 December 2019 in Advances in Medical Education and Practice
Verified
Journal Article
Open access
PDF file
SGShyam Ajay Gokani
Shyam Ajay Gokani
ESEkta Sharma
Ekta Sharma
TSTanisha Sharma
Tanisha Sharma
SMShyam Venkatesan Moudhgalya
Shyam Venkatesan Moudhgalya
SSSubothini Sara Selvendran
Subothini Sara Selvendran
NANikhil Aggarwal
Nikhil Aggarwal
Background: Critical appraisal is an important skill for clinicians of the future which medical students often have limited opportunities to develop. This study aimed to evaluate whether a national journal club session could improve medical students’ confidence with critical appraisal. Methods: 98 medical students attended a critical appraisal lecture and supervised journal article discussions. Junior doctor mentors supported students to submit discussion points as a letter-to-the-editor. An online cross-sectional survey was administered before and after the conference. Results: 74 students responded, reporting increased confidence with critically appraising research articles (median score 2 vs 4, p<0.01) and increased understanding of why critical appraisal was important to their careers (median score 3 vs 5, p<0.01). Discussion: This is the first study to demonstrate that a single national journal club session can significantly improve UK medical students’ confidence with the critical appraisal process. These opportunities are valued by medical students.

18 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
LLLouis Luke
Louis Luke
LLLiam Lee
Liam Lee
SGShyam Ajay Gokani
Shyam Ajay Gokani
DBDuncan Boak
Duncan Boak
JBJim Boardman
Jim Boardman
CPCarl Philpott
Carl Philpott
The aim is to understand the patient experience of living with chronic rhinosinusitis with nasal polyposis (CRSwNP), clinician interactions and how symptoms, smell and taste disturbance are managed. An anonymized, online survey was distributed through a UK charity, Fifth Sense, a UK otolaryngology clinic and online support groups to capture qualitative and quantitative data. Data were collected from 1st December 2022 to 1st February 2023. A total of 124 individuals participated. The majority were female (66%) and in the age range of 41–70 years; 74.2% of participants were from the UK with the rest from North America, Europe and Asia. A total of 107 participants declared they had CRSwNP. Rhinologists and general otolaryngology clinicians scored the highest for patient satisfaction whilst general practitioners scored the lowest. Satisfaction with the management of smell and taste disturbance was lower amongst all clinicians compared to overall satisfaction. Ratings correlated with response to therapy and clinician interactions. Respondents reported hyposmia/anosmia to be the most debilitating symptom. Surgery and oral steroids were considered to be effective; however, the benefit lasted less than six months (62%). Hyposmia/anosmia is a key CRSwNP symptom that has limited treatment options and is frequently undervalued by clinicians. There is a need for more effective management options, education and patient support.

29 November 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
AEAndreas Espehana
Andreas Espehana
LLLiam Lee
Liam Lee
EGElizabeth Mairenn Garden
Elizabeth Mairenn Garden
GKGabija Klyvyte
Gabija Klyvyte
SGShyam Ajay Gokani
Shyam Ajay Gokani
CPCarl Philpott
Carl Philpott
Olfactory dysfunction affects approximately 20% of the population globally, with incidence increasing over the age of 60. The pathophysiology is complex, not yet fully understood, and depends on many factors, including the underlying cause. Despite this, the present literature on olfaction is limited due to significant heterogeneity in methodological approaches. This has resulted in limited effective treatments available for olfactory dysfunction. Medications for olfactory dysfunction can be administered locally (directly to the olfactory epithelium) or systemically (orally or intravenously). Currently, there are various methods for local drug delivery to the olfactory epithelium (nasal drops, nasal sprays, atomisers, pressured meter-dosed inhalers, rinses, and exhalation delivery systems). The aims of this review are to summarise the different methods of drug delivery to the olfactory cleft, evaluate the current literature to assess which method is the most effective in delivering drugs to the olfactory epithelium, and review the medications currently available to treat olfactory dysfunction topically. Going forward, further research is required to better establish effective methods of drug delivery to the olfactory epithelium to treat smell disorders.

8 December 2022 in International Forum of Allergy & Rhinology
Verified
Journal Article
Open access
SGShyam Ajay Gokani
Shyam Ajay Gokani
NTNgan Hong Ta
Ngan Hong Ta
AEAndreas Espehana
Andreas Espehana
EGElizabeth Mairenn Garden
Elizabeth Mairenn Garden
GKGabija Klyvyte
Gabija Klyvyte
CPCarl Philpott
Carl Philpott

1 February 2018 in ClinicoEconomics and Outcomes Research
Verified
Journal Article
Open access
PDF file
SGShyam Ajay Gokani
Shyam Ajay Gokani
KEKarl Elmqvist
Karl Elmqvist
OEOsman El-Koubani
Osman El-Koubani
JAJavier Ash
Javier Ash
SBSudeep K Biswas
Sudeep K Biswas
MRMaxime Rigaudy
Maxime Rigaudy
Purpose: This study aimed to perform an economic evaluation of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service (NHS). Methods: A cost-utility analysis was conducted using data from a systematic literature review. Large bite sutures placed 10 mm from the wound edge were compared to small bite sutures 3–6 mm from the wound edge. The analysis used a 3-year time horizon in order to take into account complications including incisional hernias and surgical site infections (SSIs). Cost and benefit data were considered from the perspective of the NHS. A two-way sensitivity analysis was conducted to assess the impact of a variation in the clinical effectiveness of small bite sutures. Results: The incremental cost-effectiveness ratio was calculated to be −£482.61 per quality-adjusted life year (QALY) using the proposed small bite suture technique, indicating a cost saving to the NHS. Sensitivity analysis demonstrated that small bites are a cost-neutral technique provided that the cost of using small bites is less than £98 per patient. Small bites cost less than £20,000/QALY when they reduce either the rate of SSIs by more than 15% or the rate of hernias by more than 3.4%. Conclusion: This study proposes that small bite sutures should become the mainstay suturing technique in the closure of midline laparotomies, replacing large bite sutures, which dominate current practice. The financial savings accompanied by the decrease in SSI rates and herniation warrant the use of this new technique. The sensitivity analysis demonstrates that findings hold true for a wide range of levels of clinical effectiveness for small bites.